IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Radiance Research Academy2722http://dx.doi.org/10.31782/IJCRR.2020.121414HealthcareModern Hypolipidemic Therapy in Patients with Arterial Hypertension with High Cardiovascular Risk Under Conditions of Long-Term Ambulatory Observation AsrorovnaRuziyeva AmiraRustamovnaMuradova RailyaNegmatovichTuraev KhikmatullaMatyakubovnaNuralieva Rano220720204)6872This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

Globally, more human beings die from cardiovascular sickness (CVD) than from another motive. An envisioned 17.5 million humans died from CVD in 2012. Eighty % of those deaths are because of coronary heart assaults and strokes; greater than three-quarters of all deaths occurred in low- and center-earnings countries. In 2012, 34% of all deaths from CVD befell earlier than the age of 70 years. CVD disproportionately impacts low- and middle-earnings nations; in many nations, the financial and social burden is maximum a few of the negative and socially deprived.

Atorvastatin Rosuvastatin Atherosclerosis Hypercholesterolemia Endothelial dysfunction Arterial stiffness Cardiovascular risk